$STME
Stimcell Energetics Inc.

2024 Q1 Form 10-Q Financial Statement

#000139390524000014 Filed on January 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit Margin
Selling, General & Admin $78.86K $42.26K
YoY Change 25.17% -61.64%
% of Gross Profit
Research & Development -$21.08K $301.00
YoY Change -148.41% -98.66%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $57.78K $42.56K
YoY Change -45.77% -67.9%
Operating Profit -$57.78K -$42.56K
YoY Change -45.4% -67.77%
Interest Expense -$9.770K $17.99K
YoY Change -179.24% 67.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $120.0K -$60.55K
YoY Change -201.53% -57.6%
Income Tax
% Of Pretax Income
Net Earnings $120.0K -$60.55K
YoY Change -201.53% -57.6%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 294.7M shares 62.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.68K $22.62K
YoY Change 944.3% 27.01%
Cash & Equivalents $79.68K $22.62K
Short-Term Investments
Other Short-Term Assets $2.240K $260.00
YoY Change -64.26% -95.81%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $81.92K $22.88K
YoY Change 489.35% -4.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $3.00
YoY Change -100.0% 50.0%
TOTAL ASSETS
Total Short-Term Assets $81.92K $22.88K
Total Long-Term Assets $0.00 $3.00
Total Assets $81.92K $22.88K
YoY Change 489.52% -4.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $277.1K $648.2K
YoY Change -31.86% 54.03%
Accrued Expenses $13.10K $8.331K
YoY Change -44.53% -73.4%
Deferred Revenue
YoY Change
Short-Term Debt $322.0K $1.073M
YoY Change -64.57% 33.27%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $791.9K $2.548M
YoY Change -65.85% 14.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $791.9K $2.548M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $791.9K $2.548M
YoY Change -65.85% 14.62%
SHAREHOLDERS EQUITY
Retained Earnings -$10.17M -$10.29M
YoY Change 0.96% 3.37%
Common Stock $294.7K $62.92K
YoY Change 368.41% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$710.0K -$2.525M
YoY Change
Total Liabilities & Shareholders Equity $81.92K $22.88K
YoY Change 489.52% -4.74%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $120.0K -$60.55K
YoY Change -201.53% -57.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$37.94K -$35.33K
YoY Change -63.3% -47.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 95.00K 0.000
YoY Change 2.57% -100.0%
NET CHANGE
Cash From Operating Activities -37.94K -35.33K
Cash From Investing Activities
Cash From Financing Activities 95.00K 0.000
Net Change In Cash 57.06K -35.33K
YoY Change -630.79% -501.02%
FREE CASH FLOW
Cash From Operating Activities -$37.94K -$35.33K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54500
dei Entity Registrant Name
EntityRegistrantName
Cell MedX Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3939625
dei Entity Address Address Line1
EntityAddressAddressLine1
1130 Pender Street, West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 820
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6E 4A4
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
238-2692
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
294736373 shares
CY2023Q4 us-gaap Cash
Cash
22623 usd
CY2023Q2 us-gaap Cash
Cash
98295 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
260 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
4975 usd
CY2023Q4 us-gaap Assets
Assets
22883 usd
CY2023Q2 us-gaap Assets
Assets
103270 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
648176 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
408264 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8331 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36560 usd
CY2023Q4 fil Due To Related Party Current
DueToRelatedPartyCurrent
818950 usd
CY2023Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
1003187 usd
CY2023Q4 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
1020171 usd
CY2023Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
875130 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
52747 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
165609 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2548375 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2488750 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62923063 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62923063 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
62923 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
62923 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7272701 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7272701 usd
CY2023Q4 fil Reserves
Reserves
366493 usd
CY2023Q2 fil Reserves
Reserves
366493 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10290277 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10152777 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
62668 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
65180 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2525492 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2385480 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22883 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103270 usd
CY2023Q4 fil Costs Of Goods Sold
CostsOfGoodsSold
0 usd
CY2022Q4 fil Costs Of Goods Sold
CostsOfGoodsSold
1426 usd
fil Costs Of Goods Sold
CostsOfGoodsSold
0 usd
fil Costs Of Goods Sold
CostsOfGoodsSold
2223 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
524 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
243 usd
CY2023Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
29470 usd
CY2022Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
23267 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
59471 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
46932 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12791 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86899 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33538 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
185114 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
301 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22407 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
607 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45250 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
42562 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
132573 usd
us-gaap Operating Expenses
OperatingExpenses
93616 usd
us-gaap Operating Expenses
OperatingExpenses
277296 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
17985 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
10764 usd
us-gaap Interest Expense
InterestExpense
43884 usd
us-gaap Interest Expense
InterestExpense
20445 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-60547 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-142813 usd
us-gaap Profit Loss
ProfitLoss
-137500 usd
us-gaap Profit Loss
ProfitLoss
-297498 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6420 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
48200 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2512 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
107194 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54127 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-94613 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140012 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-190304 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62923063 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62923063 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62923063 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62923063 shares
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2009031 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-154685 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
58994 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2104722 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-142813 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
48200 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2199335 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2385480 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-76953 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8932 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2471365 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-60547 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
6420 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2525492 usd
us-gaap Profit Loss
ProfitLoss
-137500 usd
us-gaap Profit Loss
ProfitLoss
-297498 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
34197 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
20445 usd
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
9687 usd
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
0 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-629 usd
us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-66696 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4747 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-10287 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17928 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6173 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-28230 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2497 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
22857 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
60525 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75685 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-143221 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
137372 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
137372 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
13 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-718 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-75672 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6567 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98295 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24380 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22623 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17813 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
66015 usd
CY2023Q2 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
875130 usd
CY2023Q4 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
39738 usd
CY2023Q2 fil Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
39715 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10290277 usd
CY2023Q4 fil Due To Related Party Current
DueToRelatedPartyCurrent
818950 usd
CY2023Q2 fil Due To Related Party Current
DueToRelatedPartyCurrent
1003187 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
59471 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
98251 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
901551 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
118620 usd
CY2023Q4 fil Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
1020171 usd
CY2023Q2 us-gaap Loans Payable
LoansPayable
809115 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
50000 usd
CY2023Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
2747 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
52747 usd
CY2023Q2 us-gaap Other Loans Payable
OtherLoansPayable
143936 usd
CY2023Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
21673 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
165609 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
524 usd
us-gaap Gross Profit
GrossProfit
243 usd
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1622693 usd
CY2023Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
231813310 shares
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1622693 usd
CY2023Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
231813310 shares

Files In Submission

Name View Source Status
cmxc-20231130_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cmxc-20231130_pre.xml Edgar Link unprocessable
0001393905-24-000014-index-headers.html Edgar Link pending
0001393905-24-000014-index.html Edgar Link pending
0001393905-24-000014.txt Edgar Link pending
0001393905-24-000014-xbrl.zip Edgar Link pending
cmxc-20231130.htm Edgar Link pending
cmxc-20231130.xsd Edgar Link pending
cmxc_ex311.htm Edgar Link pending
cmxc_ex312.htm Edgar Link pending
cmxc_ex321.htm Edgar Link pending
cmxc_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
cmxc-20231130_def.xml Edgar Link unprocessable
cmxc-20231130_cal.xml Edgar Link unprocessable
cmxc-20231130_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending